Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1215
+0.0020 (1.67%)
Apr 24, 2026, 5:07 PM CET
Spago Nanomedical AB Earnings Call Transcripts
Fiscal Year 2025
-
A novel radiopharmaceutical platform is advancing clinical trials in Australia, showing promising tumor uptake and a favorable safety profile. The technology targets multiple tumor types, including rare cancers, and is supported by ongoing capital raising and plans for accelerated development.